Macimorelin Completed Phase 1 Trials for Healthy Subjects (HS) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00377377Oral Ghrelin Agonist in Healthy Subjects